NCT04595383

Electronic Platform for Diabetic Patients Activation

Efficacy of an Electronic Communication Platform to Activate Diabetic Patients Treated With Insulin

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 106 (estimated)
• Sponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy of an electronic platform for doctor-patient communication in order to reduce severe and non-severe hypoglycemia events as well as inadvertent hypoglycemia events.

Detailed description

This is an open randomized clinical trial without drugs. Patients with type 2 diabetes and treated with insulin will be included. Patients allocated in the intervention group will use the electronic platform as a communication channel with their health provider during the time between visits. The name of the platform is ti.care (https://ti.care/es) and it will be a complement of the control visits to resolve doubts through chats, email or video call. Health providers will answer the patient requests.

Conditions

• Hypoglycemia
• Hypoglycemia Acute

Interventions

Type	Name	Description
DEVICE	ti.care	Electronic platform for doctor-patient communication

Timeline

• Start date: 2021-10-01
• Primary completion: 2021-12-31
• Completion: 2022-05-31
• First posted: 2020-10-20
• Last updated: 2021-03-19